Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3516 Target Snapshot

Vascular endothelial growth factor receptor 1 · SINGLE PROTEIN · Mus musculus

62Compounds
4Assays
1Approved Drugs
61.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P35969. Use UniProt P35969 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P35969 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Vascular endothelial growth factor receptor 1 as ChEMBL target CHEMBL3516, mapped to UniProt P35969. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Vascular endothelial growth factor receptor 1
SINGLE PROTEIN · Mus musculus
As of 2026-09-14
ChEMBL target ID
CHEMBL3516
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P35969
Vascular endothelial growth factor receptor 1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Vascular endothelial growth factor receptor 1 is the right protein anchor across sources, using UniProt P35969 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelVascular endothelial growth factor receptor 1
UniProt AccessionP35969
Component TypeProtein
Sequence Length1333 aa

Vascular endothelial growth factor receptor 1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Vascular endothelial growth factor receptor 1, mapped to UniProt P35969. Sequence length is 1333 aa.

Mapped IDP35969
Review nameVascular endothelial growth factor receptor 1
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase III
Assay Mix

Activity Type Distribution

IC5061.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL1289494 9.68 IC50 0.21 Approved
CHEMBL86943 7.16 IC50 70.0 Preclinical
CHEMBL313433 6.85 IC50 140.0 Preclinical
CHEMBL316008 6.75 IC50 180.0 Preclinical
CHEMBL89483 6.52 IC50 300.0 Preclinical
CHEMBL86755 6.41 IC50 390.0 Preclinical
CHEMBL89363 6.4 IC50 400.0 Preclinical
CHEMBL328710 6.1 IC50 800.0 Preclinical
CHEMBL330321 6.0 IC50 1000.0 Preclinical
CHEMBL276711 5.98 IC50 1040.0 Clinical
Distribution

pChEMBL Value Distribution

13
5.0
14
5.5
4
6.0
3
6.5
1
7.0
0
7.5
0
8.0
0
8.5
0
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

TIVOZANIB
CHEMBL1289494
Approved 2017
Assay Landscape

Assay Landscape

4
Total Assays
43
Tested Compounds
2
Assay Types
Binding — 3 assays, 43 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 2 6 6.2
single protein format 1 37 5.5
Functional — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
organism-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine